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Abstract The HXK2 gene plays an important role in glucose
repression in the yeast Saccharomyces cerevisiae. Recently we
have described that the HXK2 gene product, isoenzyme 2 of
hexokinase, is located both in the nucleus and in the cytoplasm of
S. cerevisiae cells. In this work we used deletion analysis to
identify the essential part of the protein-mediating nuclear
localisation. Determinations of fructose-kinase activity and
immunoblot analysis using anti-Hxk2 antibodies in isolated
nuclei, together with observations of the fluorescence distribution
of Hxk2-GFP fusion protein in cells transformed with an
HXK2: :gfp mutant gene, indicated that the decapeptide
KKPQARKGSM, located between amino acid residues 7 and
16 of hexokinase 2, is important for nuclear localisation of the
protein. Further experimental evidence, measuring invertase
activity in wild-type and mutant cells expressing a truncated
version of the Hxk2 protein unable to enter the nucleus, shows
that a nuclear localisation of Hxk2 is necessary for glucose
repression signalling of the SUC2 gene. Furthermore, we
demonstrate using gel mobility shift analysis that Hxk2
participates in DNA-protein complexes with cis-acting regula-
tory elements of the SUC2 gene promoter.
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1. Introduction
Genetic analysis of Saccharomyces cerevisiae has led to the
identi¢cation of several genes necessary for glucose repression
and for derepression of enzyme synthesis after depletion of
glucose. Several gene products (Hxk2, Grr1, Reg1, Glc7,
Mig1, Ssn6, Tup1) act negatively in glucose repression of di-
saccharide utilising enzymes (for reviews see [1^3]). The SUC2
gene of S. cerevisiae encodes the secreted enzyme invertase
which hydrolyses sucrose and ra⁄nose. Like other genes re-
quired for utilisation of alternative carbon sources, expression
of the SUC2 gene is repressed by glucose. A central compo-
nent and also one of the ¢rst gene products acting in the
SUC2 glucose repression cascade seems to be HXK2 [4], but
it is not known how glucose modulates Hxk2 function
through these proteins. It has been proposed that the sugar-
kinase activity of hexokinase 2 is correlated with glucose re-
pression [5,6]. However, if the glucokinase gene (GLK1) is
overexpressed in a hexokinase 1/hexokinase 2 double-null mu-
tant genetic background no e¡ect on glucose repression is
observed, even in strains with a threefold increase of sugar-
phosphorylating activity [6]. This indicates that glucose re-
pression is not only associated with the sugar-kinase activity
of hexokinase 2 but that the presence of the Hxk2 protein is
also necessary to give the signal for glucose repression. Re-
cently, it has been described that an HXK2 mutation encoding
a serine to alanine change at position 15 produces a Hxk2
protein unable to undergo phosphorylation [7] and that the
transformed cells with the HXK2(S15A) mutant gene could
not provide glucose repression of invertase, suggesting that
the phosphorylation of Hxk2 is essential in vivo for glucose
signal transduction [8].
On the other hand, it has also been described that the Hxk2
is located in both the nucleus and the cytoplasm of S. cerevi-
siae cells [9] and this observation opens new possibilities to-
ward explaining the role of Hxk2 in glucose repression signal-
ling.
Here we report that the nuclear localisation of Hxk2 pro-
tein is mediated by an internal decapeptide sequence identi¢ed
as a nuclear localisation sequence (NLS) that is necessary to
direct the protein to the nucleus. We also show that a nuclear
localisation of the Hxk2 protein is necessary for glucose re-
pression signalling of the SUC2 gene. Furthermore, we show
that the nuclear Hxk2 is involved in the formation of speci¢c
DNA-protein complexes during glucose-induced repression of
the SUC2 gene. These results suggest that the Hxk2 protein
could participate in the transduction of the glucose repression
signal by interacting with transcriptional factors related to this
regulatory mechanism.
2. Materials and methods
2.1. Strains and plasmids
S. cerevisiae strains DBY1315 (MATK ura3-52 leu2-3,2-112 lys2-801
gal2) and DBY2052 (MATK hxk1: :LEU2 hxk2-202 ura3-52 leu2-3,2-
112 lys2-801 gal2) were donated by D. Botstein, and were used as
recipients in transformation experiments. Bacterial transformation
and large-scale preparation of plasmid DNA were performed in Es-
cherichia coli MC1061.
Plasmids YEp356 [10] and pRS306 [11] are yeast-E. coli shuttle
vectors.
2.2. Media, growth conditions and enzymatic analysis
Yeasts were grown on 1% yeast extract and 2% peptone supple-
mented with 4% glucose (YEPD). The cells were grown in this me-
dium until the optical density at 600 nm reached 1.0. To select for
transformants, synthetic medium with yeast nitrogen base, 2% glucose
and the adequate supplements was used.
Invertase and hexokinase were assayed as described by Moreno et
al. [12]. The protein concentrations were determined according to [13],
using bovine serum albumin as the standard. Speci¢c activities are
expressed as nmol substrate consumed/min/mg protein.
2.3. Preparation of crude protein extracts
Yeast protein extracts were prepared as follows: yeast was grown
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on 10^20 ml of rich medium (YEPD) at 28‡C until an optical density
at 600 nm of 1.0. Cells were collected, washed twice with 1 ml of 1 M
sorbitol and suspended in 100 Wl 50 mM Tris-HCl (pH 7.5) bu¡er
containing 0.2 mM EDTA, 0.5 mM dithiothreitol (DTT), 0.5 mM
phenylmethylsulphonyl £uoride (PMSF), 0.42 M NaCl and 1.5 mM
MgCl2. The cells were broken by vortexing (6U20 s) in the presence
of glass beads (0.5 g), and 400 Wl of the same bu¡er was added to the
suspension. After centrifugation at 19 000Ug (14 000 rpm) for 15 min
at 4‡C, the supernatant was used as crude protein extract.
2.4. General DNA techniques
Restriction enzymes and T4 DNA ligase were from Boehringer,
Sequenase V2.0 from USB. Radioactively labelled isotopes were
from Amersham International. The dideoxyribonucleotide chain ter-
mination procedure was used for DNA sequencing analysis [14]. All
other DNA manipulations were as previously described [15].
2.5. Construction of yeastY strains with HXK2, HXK2(S15A),
HXK2vK7 M16 , HXK2: :gfp or HXK2vK7 M16 : :gfp genes
A DNA fragment containing the complete HXK2 promoter was
isolated from the vector pRS-HXK2 [16] as a 0.88 kb SphI-NcoI
fragment and subcloned into a SphI-NcoI previously cleaved vector
pSP73-HG (this plasmid contains in a 2.75 kb fragment the complete
coding region of HXK2 gene and 254 bp of the 5P non-coding region).
The resulting plasmid pSP73-HXK2 contains in a 3.35 kb SphI-EcoRI
fragment the complete HXK2 gene under the control of its own pro-
moter. This fragment was cloned into YEp356. The resulting plasmid
was called YEp356-HXK2.
In vitro mutagenesis of HXK2 was done using the Sculptor muta-
genesis system (Amersham). The template used for mutagenesis was
bacteriophage M13mp18, with an inserted 750 bp Asp718 fragment of
the HXK2 gene and promoter obtained from pSP73-HXK2. The nu-
cleotide 5P-AAAGGGTgccATGGCCG-3P was used in the mutagene-
sis, the changed codon is shown in lower case. The 750 bp Asp718
mutated fragment from a positive phage was subcloned in YEp356-
HXK2 cleaved with the same enzymes. The resulting plasmid
YEp356-HXK2(S15A) carries a HXK2 allele codifying a hexokinase
2 with Ser15 changed to Ala.
Oligonucleotides 5P-ATGAACCATTTTATT-3P (primer 1) and 5P-
GGTTCCATGGCCGATGTG-3P (primer 2) were used to generate
construction pSP73-HXK2vK7M16 by PCR. The construct was ob-
tained by using 0.1 Wg of the primer pair 1+2, 1 Wg of pSP73-HXK2
as template, 2.5 U of Taq Polymerase (Promega), 0.2 mM dNTPs
(Pharmacia) in a total reaction volume of 25 Wl in reaction bu¡er
provided by the manufacturer for 30 cycles at 94‡C for 30 s, 55‡C
for 90 s and 72‡C for 60 s. The PCR product was isolated from 0.8%
agarose gels and ligated. The resulting plasmid (pSP73-
HXK2vK7M16) was cleaved by SphI and EcoRI to obtain an approx-
imately 3.35 kb fragment which was subcloned into a SphI-EcoRI
previously cleaved vector YEp356. The plasmid obtained, YEp356-
HXK2vK7M16, has a 30 nucleotides deletion between nucleotides
+19 and +48 of the HXK2 gene. Expression of this mutant gene
generates a truncated Hxk2 protein with similar speci¢c activity as
the wild-type hexokinase 2 but lacking amino acids from K7 to M16.
A 969 bp PstI-BglII fragment containing the gfp gene was sub-
cloned into the pSP73-HXK2 and the pSP73-HXK2vK7M16 vectors,
¢rst cleaved with PstI-BglII. The resulting plasmids pSP73-
HXK2: :gfp and pSP73-HXK2vK7M16 : :gfp were used to obtain
XhoI-BglII fragments containing respectively the HXK2 gene and
the HXK2vK7 M16 mutant gene fused in frame with the gfp gene.
These fragments were subcloned in a pRS306 plasmid ¢rst cleaved
with XhoI-BamHI revealing plasmids pRS306-HXK2: :gfp and
pRS306-HXK2vK7M16 : :gfp.
All the clones used were veri¢ed by sequencing analysis of fusion
points.
Plasmids YEp356-HXK2, YEp356-HXK2(S15A) and YEp356-
HXK2vK7M16 were used to transform the yeast strain DBY2052
and plasmids pRS306-HXK2: :gfp and pRS306-HXK2vK7M16 : :gfp
were used to transform yeast strain DBY1315.
2.6. Preparation of yeast nuclei and nuclear extracts
Nuclei were prepared from strains DBY1315; DBY2052; DBY1315
transformed with plasmids pRS306-HXK2: :gfp or pRS306-
HXK2vK7M16 : :gfp; and DBY2052 transformed with plasmids
YEp356-HXK2, YEp356-HXK2(S15A) or YEp356-HXK2vK7M16,
by the method described previously [9]. Nuclear extracts were pre-
pared as follows: the band, consisting of clean nuclei [9], collected
from near the top of the Percoll gradient was diluted three times with
lysis bu¡er (50 mM Tris-HCl, pH 7.5; 10 mM Mg2SO4 ; 1 mM
EDTA; 10 mM potassium acetate; 1 mM DTT and 1 mM PMSF),
and centrifuged at 19 000Ug for 10 min at 4‡C. The supernatant was
carefully removed by aspiration and the nuclei pellet was resuspended
in 100 Wl of lysis bu¡er. The nuclei were broken by vortexing (6U20 s)
in the presence of glass beads (0.5 g), and 200 Wl of the same bu¡er
was added to the suspension. After centrifugation at 19 000Ug for
15 min at 4‡C, the supernatant was used as nuclear extract.
2.7. DNA probes
Oligonucleotides, corresponding to both strands of the UAS ele-
ments (underlined) of the SUC2 gene [17,18], were synthesised with
an added TCGA nucleotide overhang at the 5P-terminal end.
OL34SUC2 sense: 5P-tcgaGTTTAGGAAATTATCCGGGGGCGAA-
GAAATACGC-3P ; OL34SUC2 antisense: 5P-tcgaGCGTATTTCTT-
CGCCCCCGGATAATTTCCTAAAC-3P.
The complementary strands were annealed and either end-labelled
with [K-32P]dCTP using the Klenow fragment of DNA polymerase I
or used as unlabelled competitors in protein-binding experiments.
2.8. Gel retardation assays
Binding reactions mixtures contained 10 mM HEPES (pH 7.5),
1 mM DTT, 1^5 Wg of poly(dI-dC) and 0.5 ng of end-labelled
DNA in a volume of 25 Wl. When unlabelled competitor DNA was
added, its amount is indicated in the ¢gure legends. The binding
reaction mixtures included 12 Wg (6 Wl) of protein from a nuclear
extract and after 30 min of incubation at room temperature they
were loaded onto a 4% non-denaturing polyacrylamide gel. Electro-
phoresis was carried out at 10 V/cm of gel for 45 min to 1 h in
0.5UTBE bu¡er (45 mM Tris-borate, 1 mM EDTA). Gels were dried
and autoradiographed at 370‡C with an intensifying screen.
2.9. Electrophoretic analysis, immunoblotting and antibodies
Electrophoresis of proteins (SDS-PAGE) was performed on 10%
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Table 1
Sequence present within the amino-terminal 16 residues of the Hxk2
protein and in the other known or presumed nuclear proteins
MatK1 and MatK2 [32], H2B.1 [33], Gal4 [34], H4 [35], H2A.1 [36],
Spt2 [37], Hex2 [38], Ski3 [39], Rad52 [40] and Swi5 [41]. Numbers
below an amino acid indicate the position of the amino acid within
the respective protein. Numbers in parentheses indicate the total
number of amino acids in the designated proteins.
*Consensus sequence also present at positions 595 and 875.
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polyacrylamide gels using the bu¡er system described in [19]. Western
transfer of proteins to a nitrocellulose membrane was carried out as
described in [20]. Hxk2 protein was detected by sequential incubation
with crude polyclonal antibody (1:1500 dilution) and protein A-per-
oxidase (1:4000 dilution). Speci¢c anti-Hxk2 serum was raised in
rabbits by sequential immunisation with a puri¢ed fraction of hexo-
kinase 2 [21].
3. Results
3.1. Identi¢cation of a NLS in the Hxk2 protein
Previous results obtained by measuring hexokinase activity
and by detecting Hxk2 protein with speci¢c antibodies in iso-
lated nuclei indicate a double cytosolic-nuclear localisation of
the Hxk2 protein in yeast growing in glucose-containing me-
dia. The localisation of a fraction of the Hxk2 protein in the
nucleus was further con¢rmed by expressing a Hxk2-GFP
fusion protein in yeast ruling out a possible cross-contamina-
tion during subcellular fractionation [9]. Therefore we further
investigated the presence in Hxk2 of signal sequences de-
scribed previously as nuclear-targeting signals.
A large number of NLSs have been characterised to date
and that allows analysis of their general features. All contain
a number of basic residues, but they do not conform to the
consensus bipartite sequence proposed previously [22]. How-
ever, comparison of amino acids sequences of other known or
presumed yeast nuclear proteins with the amino-terminal 16
residues of Hxk2 reveals a sequence that might be important
for nuclear targeting, Lys8-Pro-Gln-Ala-Arg12 (Table 1). A
similar sequence of two positively charged amino acids £ank-
ing three residues, one of which is proline, is present in several
other yeast nuclear proteins but this sequence is not present in
any yeast cytoplasmic proteins currently known [22,23].
The nuclear targeting ability of this putative NLS identi¢ed
in Hxk2 was determined by deletion analysis. A HXK2 mu-
tant gene (HXK2vK7 M16 ) was constructed by PCR, and this
gene has a 30 bp deletion between nucleotides +19 and +48.
The expression of this mutant gene generates a truncated
Hxk2 protein with similar speci¢c activity as the wild-type
hexokinase 2 but without the amino acids from Lys7 to Met16.
As is shown in Table 2, the wild-type phenotype was par-
tially restored after transformation of a hxk1/hxk2 double
mutant strain with a HXK2vK7 M16 -containing plasmid. The
mutant strain produced about 97% of the enzyme activity
compared to that of wild-type cells, but no hexokinase activity
was detected in isolated nuclei from this strain. However, the
wild-type phenotype was completely restored after transfor-
mation of hxk1 hxk2 double mutant strain with the
YEP356-HXK2 or the YEP356-HXK2(S15A) plasmids. More-
over, laser scanning confocal microscopy (Fig. 1) demon-
strated that Hxk2: :GFP and Hxk2vK7M16 : :GFP fusion pro-
teins were distributed in the cell in a manner consistent with a
single cytosolic localisation, such that each cell had an uni-
form distribution of green £uorescence except the vacuole
which was virtually free (Fig. 1a,d). Furthermore, nuclei pu-
ri¢ed by Percoll gradients from wild-type cells transformed
with a plasmid containing the HXK2: :gfp gene showed a
clear associated £uorescence (Fig. 1c). However, nuclei puri-
¢ed by Percoll gradients from wild-type cells transformed with
a plasmid containing the HXK2vK7 M16 : :gfp gene do not
show any associated green £uorescence (Fig. 1f).
These results were con¢rmed by immunoblot analysis using
polyclonal antibody against Hxk2 protein. As we can see in
Fig. 2, Hxk2 protein was detected in the crude extracts ob-
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Fig. 1. Detection of Hxk2-GFP fusion protein in living yeast cells.
Yeast strain DBY1315 was transformed with the integrative expres-
sion plasmids pRS306-HXK2: :gfp or pRS306-HXK2vK7M16 : :gfp.
The resulting single copy transformed strains were grown exponen-
tially in YEPD liquid media and cell-associated £uorescence was an-
alysed in whole cells transformed with the pRS306-HXK2: :gfp plas-
mid (a) or the pRS306-HXK2vK7M16 : :gfp plasmid (d) by confocal
microscopy. Panels b and e are corresponding nuclei photographed
by phase contrast. The £uorescence associated with the nuclei iso-
lated from cells transformed with the pRS306-HXK2: :gfp plasmid
(c) or the pRS306-HXK2vK7M16 : :gfp plasmid (f) was also analysed
by confocal microscopy. Confocal images of Hxk2-GFP fusion pro-
tein expression were obtained on a Bio-Ras MRC 600 inverted laser
confocal microscope using a standard £uorescein isothiocyanate ¢l-
ter providing excitation at 490 nm and emission at 527 nm. The im-
age ¢les were processed using a computer-based graphic system
(COMOS) where they were arranged and annotated. (a, d: U150;
b, e: U1000; c, f: U2000).
Table 2
Speci¢c hexokinase activity in crude extracts and nuclear extracts from di¡erent yeast strains
Strain Plasmid Hexokinase (mU/mg protein)
Crude extract Nuclear extract
DBY1315 ^ 1150 161
DBY2052 ^ n.d. n.d.
DBY2052 YEp356 n.d. n.d.
DBY2052 YEp356-HXK2 1108 153
DBY2052 YEp356-HXK2vK7M16 1120 n.d.
DBY2052 YEp356-HXK2(S15A) 1109 166
Plasmids YEp356-HXK2, YEp356-HXK2(S15A) and YEp356-HXK2vK7M16 are described in Section 2. Transformed cells with plasmid YEp356
were used as reference. Cells were grown in YEPD medium, harvested at the mid-log phase (A600, 1.0) and fractionated as described in Section 2.
The hexose-phosphorylating activity was measured using fructose as substrate. n.d., not detectable.
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tained from all the yeast strains analysed, except from the
hxk1 hxk2 double mutant strain as expected. However,
Hxk2 was found in the nuclear extract obtained from the
wild-type strain and the double mutant strain transformed
with YEP356-HXK2(S15A) plasmid, but not in the nuclear
extract obtained from the double mutant strain or the double
mutant strain transformed with a HXK2vK7 M16 -containing
plasmid.
Therefore, we can conclude that the accumulation of hexo-
kinase 2 in the nuclear fraction strongly depends on the pres-
ence of a NLS, which was localised between amino acids Lys7
and Met16 of the Hxk2 protein.
3.2. The nuclear localisation of Hxk2 is required for glucose
repression of SUC2 gene
A number of authors have proposed signalling pathway
models in order to integrate positively and negatively acting
factors into one comprehensive scheme [1^3,24,25]. These
models account for the following details : the presence of glu-
cose must be sensed in the cells; this information is trans-
duced by intracellular messengers and speci¢c target genes
are ultimately turned on or o¡. Assuming that Hxk2 is a
negative regulatory element and that a fraction of this protein
is localised inside the nucleus during the repression cycle, it
should be possible that the Hxk2 protein may interact with
positively or negatively acting factors involved in the glucose
repression cascade. Thus, our hypothesis assumes that: ¢rst,
the expression of the HXK2 gene acts as sensor of the glucose
concentration in the culture medium [26], second, a nuclear
localisation of the Hxk2 protein is required for glucose repres-
sion signalling.
Data presented in Table 3 clearly show that the wild-type
phenotype (low invertase activity in cells growing in repressing
medium) was restored after transformation of the hxk1 hxk2
double mutant with the HXK2 or the HXK2(S15A) genes.
When the hxk1 hxk2 double mutant was transformed with
the NLS mutant gene (HXK2vK7 M16) the wild-type pheno-
type was not restored. Moreover, a two-fold increase of exo-
cellular invertase activity, compared to that of hxk1 hxk2
double mutant cells, was observed, indicating an overexpres-
sion of the SUC2 gene in this genetic background. These
results revealed that nuclear localisation of Hxk2 is essential
for glucose repression signalling of the SUC2 gene.
As a ¢rst step to characterise the putative role as repressor
of Hxk2, its capacity to participate in DNA-protein com-
plexes necessary for glucose repression of SUC2 gene was
tested. When a double stranded oligonucleotide (OL34SUC2),
including the UAS sequences of the SUC2 gene [17,18], was
subjected to gel mobility shift analysis using nuclear extracts
obtained from wild-type and mutant strains as protein sour-
ces, we observed two di¡erent protein-DNA complexes (CI
and CII) with nuclear extracts prepared from glucose-grown
wild-type cells (Fig. 3, lane 2). Competition assays with a non-
labelled oligonucleotide indicated that the binding was speci¢c
in all cases (complex I was only partially displaced by the non-
labelled oligonucleotide concentrations used). Regarding the
e¡ects of hxk1 hxk2 double mutations on the formation of the
complexes, it can be seen in Fig. 3 (lane 6) that complex CI
was not formed when nuclear extracts from this strain were
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Fig. 3. Gel retardation assays with oligonucleotides which contain
the sequence from the UAS controlling regions of SUC2 gene. Gel
mobility shift assays were performed with 32P-labelled OL34SUC2
and nuclear extracts from glucose growing yeast cells of the indi-
cated strains, prepared as described in Section 2. Lane 1, no protein
added; lanes 2^5, protein from nuclear extracts obtained from wild-
type repressed cells (lane 5: with 2 Wl of anti-Hxk2 antibodies); lane
6, protein from nuclear extracts obtained from hxk1 hxk2 double
mutant repressed cells; lane 7, protein from nuclear extracts ob-
tained from hxk1 hxk2 double mutant repressed cells transformed
with plasmid YEp356-HXK2(S15A); lane 8, protein from nuclear
extracts obtained from hxk1 hxk2 double mutant repressed cells
transformed with plasmid YEp356-HXK2vK7M16. Strains: WT.
wild-type (DBY1315); DM, double mutant hxk1 hxk2 (DBY2052);
vK7M16, DBY2052 transformed with plasmid YEp356-
HXK2vK7M16 ; S15A, DBY2052 transformed with plasmid YEp356-
HXK2(S15A).
Table 3
Speci¢c activity of secreted invertase from di¡erent strains
Strain Plasmid Invertase
(mU/mg protein)
DBY1315 ^ 11
DBY2052 ^ 2800
DBY2052 YEp356 2800
DBY2052 YEp356-HXK2 12
DBY2052 YEp356-HXK2vK7M16 5700
DBY2052 YEp356-HXK2(S15A) 13
Plasmids YEp356-HXK2, YEp356-HXK2(S15A) and YEp356-
HXK2vK7M16 are described in Section 2. Transformed cells with
plasmid YEp356 were used as reference. The external invertase activ-
ity was assayed in whole cells grown in YEPD medium and harvested
at the mid-log phase (A600, 1.0).
Fig. 2. Immunoblot analysis of the nuclear fraction from di¡erent
strains. Crude and nuclear extracts from glucose growing yeast cells
of the indicated strains, prepared as described in Section 2, were
fractionated by SDS-PAGE, the proteins were transferred to nitro-
cellulose membrane and Hxk2 protein was detected with polyclonal
anti-Hxk2 antibodies. Strains: WT, wild-type (DBY1315); DM,
double mutant hxk1 hxk2 (DBY2052); vK7M16, DBY2052 trans-
formed with plasmid YEp356-HXK2vK7M16 ; S15A, DBY2052
transformed with plasmid YEp356-HXK2(S15A). CE, crude extract;
NE, nuclear extract.
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used. The wild-type phenotype was restored (Fig. 3, lane 7)
when we use nuclear extracts from repressed cells of a hxk1
hxk2 double mutant strain transformed with a plasmid con-
taining the mutant gene HXK2(S15A). However, the wild-type
phenotype was not restored when we used nuclear extracts
from repressed cells of a hxk1 hxk2 double mutant strain
transformed with a plasmid containing the NLS mutant
gene HXK2vK7 M16 , as can be seen in Fig. 3 (lane 8).
To con¢rm that Hxk2 is present in the retarded complexes
obtained with nuclear extracts from the wild-type strain, we
use a polyclonal anti-Hxk2 serum [21]. As can be observed in
Fig. 3 (lane 5) the anti-Hxk2 antiserum shifted the position of
the CI protein-DNA complex towards the top of the gel, to a
more slowly migrating complex. In the absence of protein
extract the anti-Hxk2 antiserum did not produce any complex
(data not shown).
Together, these results allow us to conclude that the Hxk2
is a component of at least one (CI) of the retarded complexes
that form the UAS elements of the SUC2 promoter with
trans-acting regulatory factors involved in the signalling of
the glucose repression cascade.
4. Discussion
These studies demonstrate that one region of yeast hexoki-
nase 2 is important in determining its nuclear localisation and
its function as mediator of glucose repression. Deletion of
Hxk2 from residues Lys7 to Met16 abolished both nuclear
localisation and glucose repression, thus indicating the impor-
tance in nuclear targeting of these amino acids of the NH2-
terminal region of the protein.
In this paper, we provide evidence supporting a novel idea.
When there is glucose in the medium, the HXK2 gene is ex-
pressed and a fraction of the Hxk2 protein, about 14% of
total hexokinase 2 activity, is found in the nuclear compart-
ment [9]. A clear correlation between nuclear location of the
protein and glucose repression of the SUC2 gene has been
demonstrated. Deletion analysis identi¢ed the essential part
of the protein-mediating nuclear localisation and glucose re-
pression between amino acid residues 7 and 16 (Tables 2 and
3; Fig. 2). To gain insight into possible functions of the Hxk2
protein in the nucleus, we used gel mobility shift analysis. This
analysis revealed that Hxk2 participates directly as part of a
complex involved in glucose repression signalling of the SUC2
gene (Fig. 3). At present, a DNA-binding function of the
Hxk2 protein does not seem to be probable. As a preliminary
hypothesis, we suppose nuclear Hxk2 to be a competitor for
transcriptional factors, thus preventing transcription of the
SUC2 gene. This preliminary hypothesis raises the question
of how Hxk2 protein localisation is regulated in response to
glucose. One possibility is that Hxk2 localisation may be regu-
lated by phosphorylation.
Although the targeting role of nuclear localisation signals
has been known for some time, more recent results indicate
that NLS-dependent nuclear protein import is precisely regu-
lated. Phosphorylation appears to be the main mechanism
controlling the nuclear transport of a number of proteins,
including transcription factors such as NF-UB, c-rel, dorsal,
and SWI5 from yeast [27]. Even nuclear localisation of the
archetypal NLS-containing simian virus 40 large tumour anti-
gen is regulated by phosphorylation of a ‘CcN’ motif close to
the NLS [28]. The regulation of nuclear transport through
phosphorylation appears to be common in eukaryotic cells
from yeast and plants to higher mammals. Yeast hexokinase
2 is known to be a phosphoprotein in vitro [29] and in vivo
[30]. The principal and perhaps sole site of phosphorylation
was identi¢ed as Ser15 by mutation to alanine, which prevents
phosphorylation in vitro [31] and in vivo [8]. Because Hxk2 is
phosphorylated at a site close to or inside NLS, it should be
interesting to examine if Ser15 phosphorylation speci¢cally
regulate NLS function. With this aim we constructed the mu-
tant gene HXK2(S15A). Expression of this gene generates a
mutant Hxk2 protein with similar speci¢c activity as the wild-
type hexokinase 2 but with a change at residue 15 from serine
to alanine. Transformation of a hxk1 hxk2 double mutant
strain with a HXK2(S15A)-containing plasmid restores both
nuclear localisation of Hxk2 and glucose repression of SUC2
gene (Tables 2 and 3; Fig. 2). These results suggest that phos-
phorylation of Ser15 does not a¡ect the nuclear targeting abil-
ity of the NLS. Thus, the Hxk2(S15A) protein can be trans-
ported to the nucleus (Fig. 2, Table 2) and in our hands, this
nuclear localisation generates the glucose repression signalling
of the SUC2 gene (Fig. 3).
We have shown that yeast hexokinase 2 combines features
which have been previously identi¢ed as important in nuclear
protein targeting: (i) a speci¢c localisation sequence, and (ii)
speci¢c binding to DNA cis-acting regulatory complexes in-
volved in control of gene expression. Further elucidation of
the mechanism controlling nuclear transport will be necessary
to understand how these features function together.
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